Filana Therapeutics (NASDAQ:FLNA) Stock Price & Analysis

–

USD

–(–)

Open

$1.22

Prev. Close

$0.809

High

$1.25

Low

$1.22

Company Profile

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.

CEORichard Jon Barry

SectorHealthcare

IndustryBiotechnology

Employees19

IPO DateJul 14, 2000

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address6801 N. Capital of Texas Highway

City / State / ZIPAustin, TX, 78731

CountryUnited States

Phone512 501 2444

Websitehttps://www.filanatx.com

Filana Therapeutics, Inc.

Company Profile

Recently from Cashu